Lizhong Su Selected Research

Inflammation (Inflammations)

7/2023

Efficacy and safety of CM310 in severe eosinophilic chronic rhinosinusitis with nasal polyps (CROWNS-1): a multicentre, randomised, double-blind, placebo-controlled phase 2 clinical trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lizhong Su Research Topics

Disease

2	Nasopharyngeal Carcinoma 11/2022 - 07/2019
2	Neoplasm Metastasis (Metastasis) 11/2022 - 01/2022
2	Neoplasms (Cancer) 05/2022 - 07/2019
1	Inflammation (Inflammations) 07/2023
1	Tinnitus 07/2023
1	Nasal Polyps (Nasal Polyp) 07/2023
1	Respiratory Tract Infections (Respiratory Tract Infection) 07/2023
1	Rhinosinusitis 07/2023
1	Carcinoma (Carcinomatosis) 01/2022
1	Squamous Cell Carcinoma of Head and Neck 11/2021
1	Lymphoma (Lymphomas) 07/2019
1	Hypoxia (Hypoxemia) 04/2014

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 11/2022 - 07/2019
2	RNA (Ribonucleic Acid)IBA 05/2022 - 11/2021
2	Long Noncoding RNAIBA 01/2022 - 11/2021
1	Biomarkers (Surrogate Marker)IBA 07/2023
1	InterleukinsIBA 07/2023
1	Monoclonal AntibodiesIBA 07/2023
1	Interleukin-13IBA 07/2023
1	Interleukin-4 (Interleukin 4)IBA 07/2023
1	CholesterolIBA 07/2023
1	ErbB Receptors (EGF Receptor)IBA 11/2022
1	MicroRNAs (MicroRNA)IBA 11/2022
1	ApoferritinsIBA 05/2022
1	E2F Transcription FactorsIBA 01/2022
1	Antisense RNA (Anti-Sense RNA)IBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 07/2019
1	Cyclin D1IBA 07/2019
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 07/2019
1	Messenger RNA (mRNA)IBA 04/2014

Therapy/Procedure

1	Crowns (Crown, Dental) 07/2023